Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

1.

Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data.

Silveira-Moriyama L, Guedes LC, Kingsbury A, Ayling H, Shaw K, Barbosa ER, Bonifati V, Quinn NP, Abou-Sleiman P, Wood NW, Petrie A, Sampaio C, Ferreira JJ, Holton J, Revesz T, Lees AJ.

Neurology. 2008 Sep 23;71(13):1021-6. doi: 10.1212/01.wnl.0000326575.20829.45.

PMID:
18809839
[PubMed - indexed for MEDLINE]
2.

Olfactory dysfunction in LRRK2 G2019S mutation carriers.

Saunders-Pullman R, Stanley K, Wang C, San Luciano M, Shanker V, Hunt A, Severt L, Raymond D, Ozelius LJ, Lipton RB, Bressman SB.

Neurology. 2011 Jul 26;77(4):319-24. doi: 10.1212/WNL.0b013e318227041c. Epub 2011 Jul 13.

PMID:
21753159
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Olfactory heterogeneity in LRRK2 related Parkinsonism.

Silveira-Moriyama L, Munhoz RP, de J Carvalho M, Raskin S, Rogaeva E, de C Aguiar P, Bressan RA, Felicio AC, Barsottini OG, Andrade LA, Chien HF, Bonifati V, Barbosa ER, Teive HA, Lees AJ.

Mov Disord. 2010 Dec 15;25(16):2879-83. doi: 10.1002/mds.23325.

PMID:
20818658
[PubMed - indexed for MEDLINE]
4.

Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.

Ruiz-Martínez J, Gorostidi A, Goyenechea E, Alzualde A, Poza JJ, Rodríguez F, Bergareche A, Moreno F, López de Munain A, Martí Massó JF.

Mov Disord. 2011 Sep;26(11):2026-31. doi: 10.1002/mds.23773. Epub 2011 May 24.

PMID:
21611983
[PubMed - indexed for MEDLINE]
5.

Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease.

Sierra M, Sánchez-Juan P, Martínez-Rodríguez MI, González-Aramburu I, García-Gorostiaga I, Quirce MR, Palacio E, Carril JM, Berciano J, Combarros O, Infante J.

Neurology. 2013 Feb 12;80(7):621-6. doi: 10.1212/WNL.0b013e31828250d6. Epub 2013 Jan 16.

PMID:
23325906
[PubMed - indexed for MEDLINE]
6.

The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?

Orr-Urtreger A, Shifrin C, Rozovski U, Rosner S, Bercovich D, Gurevich T, Yagev-More H, Bar-Shira A, Giladi N.

Neurology. 2007 Oct 16;69(16):1595-602.

PMID:
17938369
[PubMed - indexed for MEDLINE]
7.

A clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations.

Lohmann E, Leclere L, De Anna F, Lesage S, Dubois B, Agid Y, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group.

Parkinsonism Relat Disord. 2009 May;15(4):273-6. doi: 10.1016/j.parkreldis.2008.06.008. Epub 2008 Aug 21.

PMID:
18718805
[PubMed - indexed for MEDLINE]
8.

A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.

Illarioshkin SN, Shadrina MI, Slominsky PA, Bespalova EV, Zagorovskaya TB, Bagyeva GKh, Markova ED, Limborska SA, Ivanova-Smolenskaya IA.

Eur J Neurol. 2007 Apr;14(4):413-7.

PMID:
17388990
[PubMed - indexed for MEDLINE]
9.

G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies.

Gaig C, Martí MJ, Ezquerra M, Rey MJ, Cardozo A, Tolosa E.

J Neurol Neurosurg Psychiatry. 2007 Jun;78(6):626-8. Epub 2007 Jan 8.

PMID:
17210620
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers.

Marras C, Schüle B, Munhoz RP, Rogaeva E, Langston JW, Kasten M, Meaney C, Klein C, Wadia PM, Lim SY, Chuang RS, Zadikof C, Steeves T, Prakash KM, de Bie RM, Adeli G, Thomsen T, Johansen KK, Teive HA, Asante A, Reginold W, Lang AE.

Neurology. 2011 Jul 26;77(4):325-33. doi: 10.1212/WNL.0b013e318227042d. Epub 2011 Jul 13. Erratum in: Neurology. 2011 Oct 11;77(15):1501. Schuele, B [corrected to Schüle, B].

PMID:
21753163
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Subclinical signs in LRRK2 mutation carriers.

Johansen KK, White LR, Farrer MJ, Aasly JO.

Parkinsonism Relat Disord. 2011 Aug;17(7):528-32. doi: 10.1016/j.parkreldis.2011.04.014. Epub 2011 Jun 8.

PMID:
21641848
[PubMed - indexed for MEDLINE]
12.

[Clinical molecular genetics for PARK8 (LRRK2)].

Tomiyama H, Hatano T, Hattori N.

Brain Nerve. 2007 Aug;59(8):839-50. Review. Japanese.

PMID:
17713120
[PubMed - indexed for MEDLINE]
13.

Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.

Clark LN, Wang Y, Karlins E, Saito L, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K.

Neurology. 2006 Nov 28;67(10):1786-91. Epub 2006 Oct 18.

PMID:
17050822
[PubMed - indexed for MEDLINE]
14.

Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients.

Floris G, Cannas A, Solla P, Murru MR, Tranquilli S, Corongiu D, Rolesu M, Cuccu S, Sardu C, Marrosu F, Marrosu MG.

Parkinsonism Relat Disord. 2009 May;15(4):277-80. doi: 10.1016/j.parkreldis.2008.06.009. Epub 2008 Sep 20.

PMID:
18805725
[PubMed - indexed for MEDLINE]
15.

Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases.

Mamais A, Raja M, Manzoni C, Dihanich S, Lees A, Moore D, Lewis PA, Bandopadhyay R.

Neurobiol Dis. 2013 Oct;58:183-90. doi: 10.1016/j.nbd.2013.05.017. Epub 2013 Jun 5.

PMID:
23747310
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.

Gaig C, Ezquerra M, Marti MJ, Muñoz E, Valldeoriola F, Tolosa E.

Arch Neurol. 2006 Mar;63(3):377-82.

PMID:
16533964
[PubMed - indexed for MEDLINE]
17.

Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson's disease.

Kertelge L, Brüggemann N, Schmidt A, Tadic V, Wisse C, Dankert S, Drude L, van der Vegt J, Siebner H, Pawlack H, Pramstaller PP, Behrens MI, Ramirez A, Reichel D, Buhmann C, Hagenah J, Klein C, Lohmann K, Kasten M.

Mov Disord. 2010 Nov 15;25(15):2665-9. doi: 10.1002/mds.23272.

PMID:
20721915
[PubMed - indexed for MEDLINE]
18.

Clinical heterogeneity of the LRRK2 G2019S mutation.

Papapetropoulos S, Singer C, Ross OA, Toft M, Johnson JL, Farrer MJ, Mash DC.

Arch Neurol. 2006 Sep;63(9):1242-6.

PMID:
16966501
[PubMed - indexed for MEDLINE]
19.

Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment.

Gomez A, Ferrer I.

Acta Neuropathol. 2010 Aug;120(2):155-67. doi: 10.1007/s00401-010-0669-y. Epub 2010 Mar 16.

PMID:
20232069
[PubMed - indexed for MEDLINE]
20.

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.

Kachergus J, Mata IF, Hulihan M, Taylor JP, Lincoln S, Aasly J, Gibson JM, Ross OA, Lynch T, Wiley J, Payami H, Nutt J, Maraganore DM, Czyzewski K, Styczynska M, Wszolek ZK, Farrer MJ, Toft M.

Am J Hum Genet. 2005 Apr;76(4):672-80. Epub 2005 Feb 22.

PMID:
15726496
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk